Valiant Laboratories Limited
Incorporated in 1980, Valiant Laboratories Limited is a pharmaceutical ingredient manufacturing company in India having focuses on manufacturing Paracetamol.
What Valiant files
- Others61
- Board Meeting17
- Important12
- Results5
- Updates4
- Credit Ratings3
Valiant Labs clarified an omission in its Q4/FY25 Auditor's Report. The report lacked a note explaining Q4 results as the balancing figure between full-year and Q3 YTD audited financials. This clarifies presentation, not the financial figures themselves.
Valiant Labs clarified its FY26 audited financial results. It functions as a single business segment; future reports will include segment notes. A revised auditor's report was issued to add a missing balancing figure note. This correction did not alter previously disclosed financial figures.
Valiant Labs clarified its consolidated financial results for the quarter and half-year lacked segment disclosure as it operates as a single integrated business. This causes no change to past figures. Future quarters will appropriately include segment details in the notes.
Valiant Laboratories has announced a board meeting to discuss the financial results for the quarter and half-year ended December 31, 2024. The standalone revenue from operations for the quarter reached ₹3,522.84 crore, with a net profit of ₹160.01 crore. Total income stood at ₹3,589.46 crore. The consolidated results reflected similar...
Valiant Laboratories Limited has submitted its Quarterly Integrated Filing (Governance) Report for the quarter ending December 31, 2024. The report confirms that the composition of the Board of Directors and its committees complies with SEBI regulations. Notably, the company had no pending investor complaints at the start or end of...